Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives

Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives

Seasonal influenza vaccines are frequently reformulated, leading to specific challenges for continuous benefit/risk monitoring. In 2014, the European Medicines Agency started requiring annual enhanced safety surveillance (ESS). This article provides a perspective on ESS studies conducted ever since...

Full description

Bibliographic Details
Main Author: Gaël Dos Santos
Format: Article
Language:English
Published: Taylor & Francis Group 2019-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
pharmacovigilance
enhanced safety surveillance
adverse events following immunization
european medicines agency
influenza vaccine
safety signal
Online Access:http://dx.doi.org/10.1080/21645515.2019.1608745

Internet

http://dx.doi.org/10.1080/21645515.2019.1608745

Similar Items